Table 3 Utilization of medications during the index hospitalization for men and women with and without diabetes who have undergone percutaneous coronary intervention
Medications | Men | Women | ||||
|---|---|---|---|---|---|---|
Non-DM n = 905 | DM n = 155 | p | Non-DM n = 450 | DMn = 142 | p | |
% | % | % | % | |||
Aspirin | 98.6 | 99.4 | 0.425 | 99.3 | 96.5 | 0.010 |
Clopidogrel | 93.9 | 96.8 | 0.156 | 93.3 | 90.9 | 0.319 |
Heparin group | 96.1 | 96.8 | 0.699 | 96.0 | 96.5 | 0.797 |
Glycoprotein IIb/IIIa receptor inhibitors | 36.8 | 39.4 | 0.542 | 32.9 | 29.6 | 0.461 |
Beta-blockers | 78.9 | 82.6 | 0.294 | 79.6 | 76.8 | 0.477 |
ACEI/ARB | 79.6 | 87.7 | 0.017 | 86.7 | 84.5 | 0.516 |
Statins | 75.9 | 76.8 | 0.816 | 75.8 | 73.9 | 0.658 |